Zeldis Jerome B
SEC-identified person · CIK 1433982 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| PTC Therapeutics, INC. PTCT | Director | filed 2013 - 2026 |
| Nexgel, INC. NXGL | Director | filed 2021 - 2025 |
| Soligenix, INC. SNGX.OB | Director | filed 2011 - 2025 |
| Neximmune, Inc. NEXI | Executive VP of Research & Dev | filed 2021 - 2022 |
| Streamex Corp. STEX | Director | filed 2015 - 2020 |
| Sorrento Therapeutics, Inc. SRNEQ | See Remarks | filed 2016 - 2018 |
| Photovoltaic Solar Cells, Inc. XXXX | Director | filed 2016 - 2017 |
| Hepalife Technologies INC [ALQA] | Director | filed 2012 - 2017 |
| Beyond Air, Inc. XAIR | Director | filed 2017 - 2017 |
| IR Biosciences Holdings INC IRBS | Director | filed 2009 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.